Glenmark Pharmaceuticals Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -

2,276.10 +10.85 (0.48%)Updated : 10 Jul 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	-2,357.34	1,078.33	-3,272.79	523.42
Net Changein Cash	-500.99	17.44	215.24	32.50
Cash Taxes Paid	783.01	680.13	1,047.49	640.54
Net Income/ Starting Line	1,984.75	1,399.21	569.19	868.45
Total Cash Dividends Paid	-141.03	-70.44	-117.75	-136.61
Changesin Working Capital	-1,230.14	-3,208.82	-2,036.20	-1,714.35
Cashfrom Operating Activities	3,445.03	-827.60	-457.20	626.06
Cash Interest Paid	211.14	190.78	516.78	311.54
Cashfrom Financing Activities	-2,708.75	787.05	-3,906.13	-77.46
Issuance( Retirement)of Stock Net	0.76	-	1.20	0.00
Depreciation/ Depletion	573.48	486.01	630.81	611.27
Other Investing Cash Flow Items Total	74.47	752.81	5,475.77	79.27
Capital Expenditures	-1,357.71	-750.72	-914.88	-607.76
period Type	-	-	-	-
Foreign Exchange Effects	45.96	55.89	17.68	12.39
Non- Cash Items	2,116.94	496.00	379.00	860.70
Financing Cash Flow Items	-211.14	-220.85	-516.78	-464.27
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-1,283.23	2.09	4,560.89	-528.49

*All figures in crores except per share values

1,845.00+45.70(2.54%)

1,456.05+31.80(2.23%)

1,072.00+21.95(2.09%)

289.70-2.55 (-0.87%)

1,916.05-14.45 (-0.75%)

Related News